These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38845997)

  • 1. Comprehensive analysis of the gut microbiota in patients with chronic obstructive pulmonary disease of varying severity-A prospective, observational study.
    Yan J; Wu Z; Deng L; Huang C; Jing Y; Chen XY; Xu Y
    Heliyon; 2024 Jun; 10(11):e31512. PubMed ID: 38845997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variations in fecal microbial profiles of acute exacerbations and stable chronic obstructive pulmonary disease.
    Wu Y; Luo Z; Liu C
    Life Sci; 2021 Jan; 265():118738. PubMed ID: 33181175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of the sputum microbiome in COPD exacerbations and correlations between clinical indices.
    Su L; Qiao Y; Luo J; Huang R; Li Z; Zhang H; Zhao H; Wang J; Xiao Y
    J Transl Med; 2022 Feb; 20(1):76. PubMed ID: 35123490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the correlation between BMI and respiratory tract microbiota in acute exacerbation of COPD.
    Cao Y; Chen X; Shu L; Shi L; Wu M; Wang X; Deng K; Wei J; Yan J; Feng G
    Front Cell Infect Microbiol; 2023; 13():1161203. PubMed ID: 37180432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of exacerbation phenotype with the sputum microbiome in chronic obstructive pulmonary disease patients during the clinically stable state.
    Yang CY; Li SW; Chin CY; Hsu CW; Lee CC; Yeh YM; Wu KA
    J Transl Med; 2021 Mar; 19(1):121. PubMed ID: 33757530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic changes of gut and lung microorganisms during chronic obstructive pulmonary disease exacerbations.
    Sun Z; Zhu QL; Shen Y; Yan T; Zhou X
    Kaohsiung J Med Sci; 2020 Feb; 36(2):107-113. PubMed ID: 31782610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lung Mycobiota α-Diversity Is Linked to Severity in Critically Ill Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
    Enaud R; Sioniac P; Imbert S; Janvier PL; Camino A; Bui HN; Pillet O; Orieux A; Boyer A; Berger P; Gruson D; Delhaes L; Prevel R
    Microbiol Spectr; 2023 Mar; 11(2):e0506222. PubMed ID: 36976010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung microbiome composition and bronchial epithelial gene expression in patients with COPD versus healthy individuals: a bacterial 16S rRNA gene sequencing and host transcriptomic analysis.
    Ramsheh MY; Haldar K; Esteve-Codina A; Purser LF; Richardson M; Müller-Quernheim J; Greulich T; Nowinski A; Barta I; Stendardo M; Boschetto P; Korzybski D; Prasse A; Parr DG; Hohlfeld JM; Döme B; Welte T; Heath S; Gut I; Morrissey JA; Ziegler-Heitbrock L; Barer MR; Singh D; Brightling CE
    Lancet Microbe; 2021 Jul; 2(7):e300-e310. PubMed ID: 35544166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The altered sputum microbiome profile in patients with moderate and severe COPD exacerbations, compared to the healthy group in the Indian population.
    Hazra D; Sm F; Chawla K; Sintchenko V; Martinez E; Magazine R; Siddalingaiah N
    F1000Res; 2023; 12():528. PubMed ID: 37928173
    [No Abstract]   [Full Text] [Related]  

  • 10. Long non-coding RNA PVT1, a novel biomarker for chronic obstructive pulmonary disease progression surveillance and acute exacerbation prediction potentially through interaction with microRNA-146a.
    Wang Y; Lyu X; Wu X; Yu L; Hu K
    J Clin Lab Anal; 2020 Aug; 34(8):e23346. PubMed ID: 32342557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The alterations of oral, airway and intestine microbiota in chronic obstructive pulmonary disease: a systematic review and meta-analysis.
    Kou Z; Liu K; Qiao Z; Wang Y; Li Y; Li Y; Yu X; Han W
    Front Immunol; 2024; 15():1407439. PubMed ID: 38779669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut microbiota dysbiosis contributes to the development of chronic obstructive pulmonary disease.
    Li N; Dai Z; Wang Z; Deng Z; Zhang J; Pu J; Cao W; Pan T; Zhou Y; Yang Z; Li J; Li B; Ran P
    Respir Res; 2021 Oct; 22(1):274. PubMed ID: 34696775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the Change of Host and Microorganism in Chronic Obstructive Pulmonary Disease Patients Based on Metagenomic and Metatranscriptomic Sequencing.
    Yang J; Zhang Q; Zhang J; Ouyang Y; Sun Z; Liu X; Qaio F; Xu LQ; Niu Y; Li J
    Front Microbiol; 2022; 13():818281. PubMed ID: 35369515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MRI-assessed diaphragmatic function can predict frequent acute exacerbation of COPD: a prospective observational study based on telehealth-based monitoring system.
    Wei S; Lu R; Zhang Z; Wang F; Tan H; Wang X; Ma J; Zhang Y; Deng N; Chen J
    BMC Pulm Med; 2022 Nov; 22(1):438. PubMed ID: 36424599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A 16S rDNA sequencing-based analysis of airway microecology in patients with an acute exacerbation of chronic obstructive pulmonary disease: A cross-sectional study in Inner Mongolia, China.
    Zhu SF; Wu XX; Guo Y; Li PF; Wang JR; Liu M; Luo CW; Yuan XZ; Li SW
    Front Med (Lausanne); 2022; 9():946238. PubMed ID: 36314008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Bufei Jianpi Formula Improves Mucosal Immune Function by Remodeling Gut Microbiota Through the SCFAs/GPR43/NLRP3 Pathway in Chronic Obstructive Pulmonary Disease Rats.
    Mao J; Li Y; Bian Q; Xuan Y; Li J; Wang Z; Feng S; Liu X; Tian Y; Li S
    Int J Chron Obstruct Pulmon Dis; 2022; 17():1285-1298. PubMed ID: 35673595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The sputum microbiome associated with different sub-types of AECOPD in a Chinese cohort.
    Wang J; Chai J; Sun L; Zhao J; Chang C
    BMC Infect Dis; 2020 Aug; 20(1):610. PubMed ID: 32811432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Butyrate inhibits iILC2-mediated lung inflammation via lung-gut axis in chronic obstructive pulmonary disease (COPD).
    Jiang M; Li Z; Zhang F; Li Z; Xu D; Jing J; Li F; Wang J; Ding J
    BMC Pulm Med; 2023 May; 23(1):163. PubMed ID: 37173731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Diagnostic and Assessment Value of Plasma Pentraxin 3 in Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
    Gu Y; Li P; Xiao Y; Zhang J; Su X
    Int J Chron Obstruct Pulmon Dis; 2023; 18():1391-1400. PubMed ID: 37456914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of Chinese and Western Medicine Optimizes the Intestinal Microbiota of Exacerbated Chronic Obstructive Pulmonary Disease in Rats.
    Li X; Li Y; Mao J; Bian Q; Xuan Y; Shen T; Li S
    Evid Based Complement Alternat Med; 2021; 2021():9975407. PubMed ID: 34539809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.